Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies

Joint Bone Spine. 2018 May;85(3):375-376. doi: 10.1016/j.jbspin.2017.04.004. Epub 2017 Apr 20.

Authors

Wladimir Mauhin¹, Kuberaka Mariampillai¹, Yves Allenbach¹, Jean-Luc Charuel², Lucile Musset², Olivier Benveniste³

Affiliations

¹ UMR 974, UPMC, Internal Medicine and Clinical Immunology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
² Immunology Department, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.
³ UMR 974, UPMC, Internal Medicine and Clinical Immunology, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: Olivier.benveniste@aphp.fr.

PMID: 28435082
DOI: 10.1016/j.jbspin.2017.04.004

No abstract available

Keywords: Anti-mitochondrial antibodies; Auto-antibodies; Myositis; Primary biliary cholangitis.

Publication types

Letter

MeSH terms

Adult
Aged
Autoantibodies / immunology*
Databases, Factual
Female
Humans
Male
Middle Aged
Myositis / immunology*
Myositis / physiopathology*
Prognosis
Retrospective Studies
Sensitivity and Specificity
Severity of Illness Index

Substances

Autoantibodies